# Revolution Medicines, Inc. (RVMD) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Revolution Medicines, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RVMD/mda/fy2025/): filed 2026-02-25; accession 0001193125-26-071563 (https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RVMD/mda/fy2024/): filed 2025-02-26; accession 0000950170-25-027736 (https://www.sec.gov/Archives/edgar/data/1628171/000095017025027736/rvmd-20241231.htm)
- [FY 2023 MD&A](/company/RVMD/mda/fy2023/): filed 2024-02-26; accession 0000950170-24-020145 (https://www.sec.gov/Archives/edgar/data/1628171/000095017024020145/rvmd-20231231.htm)
- [FY 2022 MD&A](/company/RVMD/mda/fy2022/): filed 2023-02-27; accession 0000950170-23-004645 (https://www.sec.gov/Archives/edgar/data/1628171/000095017023004645/rvmd-20221231.htm)
- [FY 2021 MD&A](/company/RVMD/mda/fy2021/): filed 2022-02-28; accession 0000950170-22-002297 (https://www.sec.gov/Archives/edgar/data/1628171/000095017022002297/rvmd-20211231.htm)

Back to /company/RVMD/